| Renee Marie Simpson, CRNA | |
|
400 N Pepper Ave, Colton, CA 92324-1801 | |
| (909) 580-1000 | |
| Not Available |
| Full Name | Renee Marie Simpson |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 7 Years |
| Location | 400 N Pepper Ave, Colton, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780114728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 95000724 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inland Empire Anesthesia Medical Group, Inc | 1052310331 | 26 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
Acute kidney injury (AKI), also known as acute renal failure, is one of the main contributors to death and disability worldwide, yet no preventive treatment for the condition has been established. In a new study published in the journal Cell Death and Differentiation, a team of researchers led by scientists from Roswell Park Cancer Institute reports that they have identified 10 genes whose inhibition appears to protect kidney cells.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company is now enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at ten sites across the country.
On the heels of the 2014 hurricane season, researchers are calling for home parenteral and enteral nutrition (HPEN) consumers and their homecare providers to have a comprehensive emergency preparedness plan (EPP) to ensure that special needs are met during the time of a disaster.
› Verified 7 days ago
| Entity Name | Inland Empire Anesthesia Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861502841 PECOS PAC ID: 1052310331 Enrollment ID: O20061214000268 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
Acute kidney injury (AKI), also known as acute renal failure, is one of the main contributors to death and disability worldwide, yet no preventive treatment for the condition has been established. In a new study published in the journal Cell Death and Differentiation, a team of researchers led by scientists from Roswell Park Cancer Institute reports that they have identified 10 genes whose inhibition appears to protect kidney cells.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company is now enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at ten sites across the country.
On the heels of the 2014 hurricane season, researchers are calling for home parenteral and enteral nutrition (HPEN) consumers and their homecare providers to have a comprehensive emergency preparedness plan (EPP) to ensure that special needs are met during the time of a disaster.
› Verified 7 days ago
| Entity Name | Lgibson Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417473323 PECOS PAC ID: 3476827288 Enrollment ID: O20170918001886 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
Acute kidney injury (AKI), also known as acute renal failure, is one of the main contributors to death and disability worldwide, yet no preventive treatment for the condition has been established. In a new study published in the journal Cell Death and Differentiation, a team of researchers led by scientists from Roswell Park Cancer Institute reports that they have identified 10 genes whose inhibition appears to protect kidney cells.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company is now enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at ten sites across the country.
On the heels of the 2014 hurricane season, researchers are calling for home parenteral and enteral nutrition (HPEN) consumers and their homecare providers to have a comprehensive emergency preparedness plan (EPP) to ensure that special needs are met during the time of a disaster.
› Verified 7 days ago
| Entity Name | Liberty Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518626258 PECOS PAC ID: 3870985641 Enrollment ID: O20220128000603 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
Acute kidney injury (AKI), also known as acute renal failure, is one of the main contributors to death and disability worldwide, yet no preventive treatment for the condition has been established. In a new study published in the journal Cell Death and Differentiation, a team of researchers led by scientists from Roswell Park Cancer Institute reports that they have identified 10 genes whose inhibition appears to protect kidney cells.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company is now enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at ten sites across the country.
On the heels of the 2014 hurricane season, researchers are calling for home parenteral and enteral nutrition (HPEN) consumers and their homecare providers to have a comprehensive emergency preparedness plan (EPP) to ensure that special needs are met during the time of a disaster.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Renee Marie Simpson, CRNA 16 Garner Dr, Novato, CA 94947-4428 Ph: (209) 712-2731 | Renee Marie Simpson, CRNA 400 N Pepper Ave, Colton, CA 92324-1801 Ph: (909) 580-1000 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
Acute kidney injury (AKI), also known as acute renal failure, is one of the main contributors to death and disability worldwide, yet no preventive treatment for the condition has been established. In a new study published in the journal Cell Death and Differentiation, a team of researchers led by scientists from Roswell Park Cancer Institute reports that they have identified 10 genes whose inhibition appears to protect kidney cells.
Rexahn Pharmaceuticals, Inc. a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, is providing an overview of its three clinical development programs and Year for the year ended December 31, 2013.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company is now enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at ten sites across the country.
On the heels of the 2014 hurricane season, researchers are calling for home parenteral and enteral nutrition (HPEN) consumers and their homecare providers to have a comprehensive emergency preparedness plan (EPP) to ensure that special needs are met during the time of a disaster.
› Verified 7 days ago
Mr. Richard William Reis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 North Pepper Avenue 2nd Floor, Anesthesia Dept., Inland Empire Anesthesia Medical Group, Inc., Colton, CA 92324 Phone: 909-580-2440 Fax: 909-580-2441 | |
Elizabeth Karenina Manullang, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 877-873-2762 | |
Ivan Stiger, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-2440 | |
Mr. Michael T Reid, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 E Washington St, Ste. 100, Colton, CA 92324 Phone: 909-370-2190 | |
Daniel Hioe, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-2440 | |
Mr. Dale Arthur Reile, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 400 N Pepper Ave Fl 2, Inland Empire Anesthesia Medical Group, Inc., Colton, CA 92324 Phone: 909-580-2440 Fax: 909-580-2441 | |
Cheryl Sisler Carr, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 400 N Pepper Ave, Anesthesia Dept, 2nd Floor, Colton, CA 92324 Phone: 909-580-2440 |